Hanson & Doremus Investment Management Teva Pharmaceutical Industries LTD Transaction History

Hanson & Doremus Investment Management

$627 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$7.38 - $10.4 $26,353 - $37,138	-3,571 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$7.33 - $9.39 $7,586 - $9,718	-1,035 Reduced 22.47%	3,571 $34,000
Q3 2021 Oct 21, 2021	SELL	$8.38 - $10.18 $115,945 - $140,850	-13,836 Reduced 75.02%	4,606 $44,000
Q2 2021 Jul 22, 2021	BUY	$9.9 - $11.56 $35,590 - $41,558	3,595 Added 24.21%	18,442 $166,000
Q1 2021 May 03, 2021	SELL	$10.34 - $12.81 $2,585 - $3,202	-250 Reduced 1.66%	14,847 $171,000
Q4 2020 Feb 01, 2021	SELL	$8.61 - $11.04 $28,800 - $36,928	-3,345 Reduced 18.14%	15,097 $146,000
Q3 2020 Oct 19, 2020	SELL	$8.57 - $12.69 $2,656 - $3,933	-310 Reduced 1.65%	18,442 $166,000
Q2 2020 Jul 17, 2020	SELL	$8.12 - $13.12 $22,102 - $35,712	-2,722 Reduced 12.68%	18,752 $231,000
Q1 2020 Apr 24, 2020	SELL	$6.69 - $13.45 $1,752 - $3,523	-262 Reduced 1.21%	21,474 $192,000
Q4 2019 Jan 16, 2020	SELL	$6.53 - $10.72 $56,040 - $91,999	-8,582 Reduced 28.31%	21,736 $213,000
Q3 2019 Oct 18, 2019	SELL	$6.16 - $9.6 $70,722 - $110,217	-11,481 Reduced 27.47%	30,318 $209,000
Q2 2019 Jul 18, 2019	BUY	$8.12 - $15.72 $3,207 - $6,209	395 Added 0.95%	41,799 $386,000
Q1 2019 Apr 23, 2019	SELL	$15.58 - $20.01 $41,629 - $53,466	-2,672 Reduced 6.06%	41,404 $0
Q4 2018 Jan 31, 2019	SELL	$14.59 - $23.84 $65,698 - $107,351	-4,503 Reduced 9.27%	44,076 $680,000
Q3 2018 Oct 24, 2018	BUY	$21.06 - $25.65 $5,833 - $7,105	277 Added 0.57%	48,579 $0
Q2 2018 Aug 08, 2018	SELL	$16.77 - $24.71 $2,448 - $3,607	-146 Reduced 0.3%	48,302 $1.18 Million
Q1 2018 May 10, 2018	BUY	$16.68 - $22.07 $56,011 - $74,111	3,358 Added 7.45%	48,448 $828,000
Q4 2017 Jan 25, 2018	SELL	$11.23 - $19.1 $172,324 - $293,089	-15,345 Reduced 25.39%	45,090 $854,000
Q3 2017 Oct 26, 2017	BUY	$15.41 - $32.17 $931,303 - $1.94 Million	60,435	60,435 $0

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$752 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$636 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$566 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$505 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$463 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account